Use of a CD40:CD154 binding interruptor to treat immunological complications of the eye
A Standard patent application filed on 19 October 2000 credited to Dana, M. Reza ; Vaishnaw, Akshay K. ; Adelman, Burt ; Lobb, Roy ; Burkly, Linda C

Details

Application number :

12164  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Use of a CD40:CD154 binding interruptor to treat immunological complications of the eye  

Inventor :

Dana, M. Reza ; Vaishnaw, Akshay K. ; Adelman, Burt ; Lobb, Roy ; Burkly, Linda C  

Agent name :

Cullens Patent and Trade Mark Attorneys  

Address for service :

GPO Box 1074 BRISBANE QLD 4001  

Filing date :

19 October 2000  

Associated companies :

 

Applicant name :

Biogen Idec MA Inc.  

Applicant address :

14 Cambridge Center, Cambridge, MA 02142, United States of America  

Old name :

Biogen, Inc. ; Schepens Eye Research Institute  

Original Source :

Go